India continues to use banned liver damaging drug
Finland has recently banned the widely used anti-fever drug Nimesulide, as its indiscriminate use has been implicated for damaging the liver. Almost 109 cases of adverse reactions were reported in the country within a span of five years. Sixty-six of these were related to liver toxicity. However, in India the drug continues to be used on a large-scale, with its annual sale amounting to Rs 200 crore.
However, now the Union ministry of health and family welfare is reviewing the safety of the drug. "The final decision will be taken by the end of this year after reviewing available data and expert opinion," says Ashwini Kumar, drug controller general of India. However many experts are sceptical. "As there is gross underreporting in our country, the decision could be biased," says Ajay Gambhir, secretary of the Indian Academy of Paediatrics, New Delhi. Moreover, being ignorant about its adverse effect, many people take the medicine without a doctor's prescription. "The drug manufacturers or the government do not provide information about the drug even to the doctors. This is a must considering the consumers' behaviour," says Harish K Pende from the Lady Harding Medical College, New Delhi.
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.
Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.